Ultrasound Guided Erector Spinae Plane Block

Gözde Gamze Uzun

Status: Completed

Conditions: Breast Diseases

Treatments: Procedure: Erector Spinae Plane Block; Procedure: Standart therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT06657092

Kocaeli Univercity

Details and patient eligibility

About

Patients were randomized into two groups, ESP and control. Single-shot ultrasound (US)-guided ESP block with 20 ml 0.25% bupivacaine at the T4 vertebral level was performed preoperatively to all patients in the ESP group. The control group received no intervention. Patients in both groups were provided with intravenous patient-controlled analgesia device containing morphine for postoperative analgesia.

Enrollment: 42 patients

Sex: Female

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. 18-65 age
2. Patients who scheduled for bilateral reduction mammoplasty
3. ASA Class I-II

Exclusion criteria

1. Coagulopaty

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

42 participants in 2 patient groups

erector spinae plane block group

Active Comparator group

Description:

Single-shot ultrasound (US)-guided ESP block with 20 ml 0.25% bupivacaine at the T4 vertebral level

Treatment:

Procedure: Erector Spinae Plane Block

control group

Active Comparator group

Description:

morphine pca to patient

Treatment:

Procedure: Standart therapy